Immunopathogenesis of liver fibrosis in steatotic liver disease

被引：0
|
作者：
Woo, Chaerin [1 ]
Jeong, Won -Il [1 ,2 ]
机构：
[1] Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Lab Liver Res, Daejeon, South Korea
[2] Korea Adv Inst Sci & Technol, Ctr Hepat Glutamate & Its Funct, Daejeon, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2024年 / 30卷 / 02期
关键词：
Fibrosis; Hepatic stellate cells; Inflammation; Immunologic factors; Fatty acids;
D O I：
10.3350/cmh.2024.0113
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD)
    Barchetta, Ilaria
    Zampieri, Michele
    Cimini, Flavia Agata
    Dule, Sara
    Sentinelli, Federica
    Passarella, Giulia
    Oldani, Alessandro
    Karpach, Katsiaryna
    Bacalini, Maria Giulia
    Baroni, Marco Giorgio
    Reale, Anna
    Cavallo, Maria Gisella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [42] Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis
    Fan, Xingyu
    Wang, Yueyue
    Wang, Yue
    Duan, Hao
    Du, Yijun
    Pan, Tianrong
    Zhong, Xing
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [43] Serial Liver Stiffness Measurement and Fibrosis-4 Scores in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Goyal, Tanvi
    Song, Michael W.
    Suresh, Deepika
    Jasty, Venkata S. J.
    Urias, Esteban
    Wijarnpreecha, Karn
    Wong, Yu Jun
    Chen, Vincent L.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (11) : 4250 - 4258
  • [44] Liver Fibrosis in Alcoholic Liver Disease
    Bataller, Ramon
    Gao, Bin
    SEMINARS IN LIVER DISEASE, 2015, 35 (02) : 146 - 156
  • [45] Pemafibrate Reduced Liver Stiffness in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease Complicated with Hyperlipidemia and Liver Fibrosis with a Fibrosis-4 Index Above 1.3
    Ichikawa, Tatsuki
    Yamashima, Mio
    Yamamichi, Shinobu
    Koike, Makiko
    Nakano, Yusuke
    Yajima, Hiroyuki
    Miyazaki, Osamu
    Ikeda, Tomonari
    Okamura, Takuma
    Komatsu, Naohiro
    Sugio, Sayuri
    Yoshino, Miruki
    Miyaaki, Hisamitsu
    INTERNAL MEDICINE, 2024,
  • [46] Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation
    Liukkonen, Ville
    Semenova, Maria
    Hyvarinen, Kati
    Lauronen, Jouni
    Partanen, Jukka
    Arola, Johanna
    Nordin, Arno
    Farkkila, Martti
    Aberg, Fredrik
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [47] FEASIBILITY OF FAT FREE LIVER VOLUME AS A BIOMARKER IN STEATOTIC LIVER DISEASE
    Brannstrom, Emil
    Rorsman, Fredrik
    Vessby, Johan
    Hockings, Paul
    Johansson, Lars
    HEPATOLOGY, 2024, 80 : S662 - S663
  • [48] Sex Differences in Adverse Liver and Nonliver Outcomes in Steatotic Liver Disease
    Yan, Taotao
    Zhang, Xinrong
    Wong, Tyler
    Cheung, Ramsey
    Nguyen, Mindie H.
    JAMA NETWORK OPEN, 2024, 7 (12)
  • [49] Metabolic dysfunction-associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis
    Kobayashi, Natsuko
    Tada, Toshifumi
    Nishimura, Takashi
    Matono, Tomomitsu
    Yuri, Yukihisa
    Takashima, Tomoyuki
    Aizawa, Nobuhiro
    Ikeda, Naoto
    Fukunishi, Shinya
    Hashimoto, Mariko
    Ohyanagi, Mitsumasa
    Enomoto, Hirayuki
    Iijima, Hiroko
    HEPATOLOGY RESEARCH, 2024, 54 (05) : 429 - 438
  • [50] CLINICAL OUTCOMES OF STEATOTIC LIVER DISEASE IN JAPAN
    Kogiso, Tomomi
    Ogasawara, Yuri
    Taniai, Makiko
    Nakai, Yousuke
    HEPATOLOGY, 2024, 80 : S804 - S805
12345